Molecular Diagnostics Cancer Oncology - Global Market Size, Strategy and Forecasts - 2019 to 2023

$3,000.00

Companion Diagnostics and Liquid Biopsy drive market growth while lowering costs.....”

 300 pages packed with information

Report Date:  April 5, 2019

 A market that just keeps on growing.  Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge.  Learn all about it in this new report from Howe Sound Research.  A range of dynamic trends are pushing market growth and company valuations.  Trends like ......

 

  • personalized medicine
  • pharmacogenomics
  • liquid biopsy
  • emergence of new economies with large markets
  • greater understanding of the role of genetic material in Disease and Health

 Exciting technical developments especially in the area of pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

 In addition customization work, breakouts for particular segments, assistance and support is included free of charge with every report.

 "Molecular Diagnostics Cancer Oncology - Global Market Size, Strategy and Forecasts - 2019 to 2023" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2018 United States Medicare Fee Payment Schedules to help understand test pricing in detail.  See lists of all current FDA Approved Molecular Diagnostic Tests. Make facilities planning decisions.  Forecast demand for new testing regimes or technologies.  Make research investment decisions.  Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges.  Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.  Again, assistance in using the information is normally provided without additional charges. 

 The report includes detailed breakouts for 18 Countries and 4 Regions.  A detailed breakout for any country in the world is available to purchasers of the report.

See the Table of Contents.  Hundreds of pages of useful information, hard data and up to date market developments.

Make investment decisions and valuations with confidence using the latest data.

“ This is an impressive piece of work.”    Doug Buchanan, Managing Director and CEO BC Biomedical Laboratories Ltd.

The report includes detailed breakouts for 15 Countries and 4 Regions.  A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

 

Make investment decisions and valuations with confidence using the latest data.  

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. 

 

He is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

B.Sc. (Chemistry) University of BC

M.B.A. (Finance and Policy) University of BC

Market Research  - Burke Institute

Finance for Senior Executives - Harvard Business School

Related products